<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40919347</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1671-5411</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of geriatric cardiology : JGC</Title><ISOAbbreviation>J Geriatr Cardiol</ISOAbbreviation></Journal><ArticleTitle>Robot-assisted percutaneous coronary intervention: a prospective, multicenter, randomized controlled, non-inferiority clinical trial.</ArticleTitle><Pagination><StartPage>725</StartPage><EndPage>735</EndPage><MedlinePgn>725-735</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.26599/1671-5411.2025.08.008</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the safety and effectiveness of robot-assisted percutaneous coronary intervention (R-PCI) compared to traditional manual percutaneous coronary intervention (M-PCI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective, multicenter, randomized controlled, non-inferior clinical trial enrolled patients with coronary heart disease who met the inclusion criteria and had indications for elective percutaneous coronary intervention. Participants were randomly assigned to either the R-PCI group or the M-PCI group. Primary endpoints were clinical and technical success rates. Clinical success was defined as visually estimated residual post-percutaneous coronary intervention stenosis &lt; 30% with no 30-day major adverse cardiac events. Technical success in the R-PCI group was defined as successful completion of percutaneous coronary intervention using the ETcath200 robot-assisted system, without conversion to M-PCI in the event of a guidewire or balloon/stent catheter that was unable to cross the vessel or was poorly supported by the catheter. Secondary endpoints included total procedure time, percutaneous coronary intervention procedure time, fluoroscopy time, contrast volume, operator radiation exposure, air kerma, and dose-area product.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The trial enrolled 152 patients (R-PCI: 73 patients, M-PCI: 79 patients). Lesions were predominantly B2/C type (73.6%). Both groups achieved 100% clinical success rate. No major adverse cardiac events occurred during the 30-day follow-up. The R-PCI group had a technical success rate of 100%. The R-PCI group had longer total procedure and fluoroscopy times, but lower operator radiation exposure. The percutaneous coronary intervention procedure time, contrast volume, air kerma, and dose-area product were similar between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For certain complex lesions, performing percutaneous coronary intervention using the ETcath200 robot-assisted system is safe and effective and does not result in conversion to M-PCI.</AbstractText><CopyrightInformation>&#xa9; 2025 JGC All rights reserved; www.jgc301.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhi-Jian</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yue-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Li-Xia</ForeName><Initials>LX</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Beijing WeMed Medical Equipment Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Beijing WeMed Medical Equipment Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Dong-Mei</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yu-Jie</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Geriatr Cardiol</MedlineTA><NlmUniqueID>101237881</NlmUniqueID><ISSNLinking>1671-5411</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40919347</ArticleId><ArticleId IdType="pmc">PMC12411764</ArticleId><ArticleId IdType="doi">10.26599/1671-5411.2025.08.008</ArticleId><ArticleId IdType="pii">jgc-22-8-725</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lawton JS, Tamis-Holland JE, Bangalore S, et al 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e18&#x2013;e114. doi: 10.1161/CIRCULATIONAHA.121.057538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.057538</ArticleId><ArticleId IdType="pubmed">34882435</ArticleId></ArticleIdList></Reference><Reference><Citation>Vano E, Kleiman NJ, Duran A, et al Radiation cataract risk in interventional cardiology personnel. Radiat Res. 2010;174:490&#x2013;495. doi: 10.1667/RR2207.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1667/RR2207.1</ArticleId><ArticleId IdType="pubmed">20726724</ArticleId></ArticleIdList></Reference><Reference><Citation>Venneri L, Rossi F, Botto N, et al Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: insights from the National Research Council&#x2019;s Biological Effects of Ionizing Radiation VII Report. Am Heart J. 2009;157:118&#x2013;124. doi: 10.1016/j.ahj.2008.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2008.08.009</ArticleId><ArticleId IdType="pubmed">19081407</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreassi MG, Piccaluga E, Guagliumi G, et al Occupational health risks in cardiac catheterization laboratory workers. Circ Cardiovasc Interv. 2016;9:e003273. doi: 10.1161/CIRCINTERVENTIONS.115.003273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.115.003273</ArticleId><ArticleId IdType="pubmed">27072525</ArticleId></ArticleIdList></Reference><Reference><Citation>Orme NM, Rihal CS, Gulati R, et al Occupational health hazards of working in the interventional laboratory: a multisite case control study of physician and allied staff. J Am Coll Cardiol. 2015;65:820&#x2013;826. doi: 10.1016/j.jacc.2014.11.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.11.056</ArticleId><ArticleId IdType="pubmed">25720626</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel TM, Shah SC, Soni YY, et al Comparison of robotic percutaneous coronary intervention with traditional percutaneous coronary intervention: a propensity score-matched analysis of a large cohort. Circ Cardiovasc Interv. 2020;13:e008888. doi: 10.1161/CIRCINTERVENTIONS.119.008888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.119.008888</ArticleId><ArticleId IdType="pubmed">32406263</ArticleId></ArticleIdList></Reference><Reference><Citation>Durand E, Sabatier R, Smits PC, et al Evaluation of the R-One robotic system for percutaneous coronary intervention: the R-EVOLUTION study. EuroIntervention. 2023;18:e1339&#x2013;e1347. doi: 10.4244/EIJ-D-22-00642.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-22-00642</ArticleId><ArticleId IdType="pmc">PMC10068861</ArticleId><ArticleId IdType="pubmed">36602883</ArticleId></ArticleIdList></Reference><Reference><Citation>Madder RD, VanOosterhout S, Mulder A, et al Impact of robotics and a suspended lead suit on physician radiation exposure during percutaneous coronary intervention. Cardiovasc Revasc Med. 2017;18:190&#x2013;196. doi: 10.1016/j.carrev.2016.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carrev.2016.12.011</ArticleId><ArticleId IdType="pubmed">28041859</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Moses JW, Sosa FA, et al Robotic-enhanced PCI compared to the traditional manual approach. J Invasive Cardiol. 2014;26:318&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">24993988</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud E, Naghi J, Ang L, et al Demonstration of the safety and feasibility of robotically assisted percutaneous coronary intervention in complex coronary lesions: results of the CORA-PCI study (Complex Robotically Assisted Percutaneous Coronary Intervention) JACC Cardiovasc Interv. 2017;10:1320&#x2013;1327.</Citation><ArticleIdList><ArticleId IdType="pubmed">28683937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagiyama K, Mitsutake Y, Ueno T, et al Successful introduction of robotic-assisted percutaneous coronary intervention system into Japanese clinical practice: a first-year survey at single center. Heart Vessels. 2021;36:955&#x2013;964. doi: 10.1007/s00380-021-01782-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-021-01782-6</ArticleId><ArticleId IdType="pmc">PMC7839282</ArticleId><ArticleId IdType="pubmed">33502572</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, et al 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720&#x2013;3826. doi: 10.1093/eurheartj/ehad191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad191</ArticleId><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai GY, Chen Z, Liu RF, et al First-in-human evaluation of an independently developed Chinese robot-assisted system for percutaneous coronary intervention. J Geriatr Cardiol. 2022;19:743&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9618848</ArticleId><ArticleId IdType="pubmed">36338278</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa MA, Angiolillo DJ, Tannenbaum M, et al Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial) Am J Cardiol. 2008;101:1704&#x2013;1711. doi: 10.1016/j.amjcard.2008.02.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.02.053</ArticleId><ArticleId IdType="pubmed">18549844</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezerra HG, Mehanna E, W Vetrovec G, et al Longitudinal Geographic Miss (LGM) in robotic assisted versus manual percutaneous coronary intervention. J Interv Cardiol. 2015;28:449&#x2013;455. doi: 10.1111/joic.12231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joic.12231</ArticleId><ArticleId IdType="pubmed">26489972</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisz G, Metzger DC, Caputo RP, et al Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) study. J Am Coll Cardiol. 2013;61:1596&#x2013;1600. doi: 10.1016/j.jacc.2012.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.12.045</ArticleId><ArticleId IdType="pubmed">23500318</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters D, Reeves RR, Patel M, et al Complex robotic compared to manual coronary interventions: 6- and 12-month outcomes. Catheter Cardiovasc Interv. 2019;93:613&#x2013;617. doi: 10.1002/ccd.27867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.27867</ArticleId><ArticleId IdType="pubmed">30456889</ArticleId></ArticleIdList></Reference><Reference><Citation>Smitson CC, Ang L, Pourdjabbar A, et al Safety and feasibility of a novel, second-generation robotic-assisted system for percutaneous coronary intervention: first-in-human report. J Invasive Cardiol. 2018;30:152&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">29335386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangels D, Fregoso A, Ang L, et al Resource utilization during elective robotic-assisted percutaneous coronary intervention. J Invasive Cardiol. 2020;32:E321&#x2013;E325.</Citation><ArticleIdList><ArticleId IdType="pubmed">32829309</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi B, Sharma P, Arora S, et al Safety and feasibility of robotic assisted percutaneous coronary intervention compared to standard percutaneous coronary intervention: a systematic review and meta-analysis. Indian Heart J. 2021;73:549&#x2013;554. doi: 10.1016/j.ihj.2021.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ihj.2021.08.006</ArticleId><ArticleId IdType="pmc">PMC8514414</ArticleId><ArticleId IdType="pubmed">34627567</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>